Investor buy-side · Entry screen · UK
A market entry and acquisition screen in UK consumer health.
A flat-looking category concealed double-digit needs-based niches and ten potential targets.
Category sized bottom-up
Needs-based resegmentation
16 expert interviews
Transaction
PE / investor
Consumer health
The challenge
The investor needed to know whether UK vitamins and supplements merited entry, which model could win and which available companies deserved a closer look - without commissioning a full diligence cycle.
The work
The market was resegmented by consumer need rather than product type. Interviews, store and site visits, web traffic and bottom-up P&Ls showed a flat category concealing fast-growth niches - and that advertising and differentiation, not inherited trust, explained brand trajectory.
The result
The review supported a premium, vertically integrated online model focused on needs-based niches, rejected the personalised route and ranked ten targets. Amazon depth and subscription economics remained explicit open risks; the work informed entry, not a transaction.
One of twelve case studies in the record. The full set - corporate strategy, transactions and capital commitments - sits in the case studies index.
Engagements were won and led by Elliot Ronald and delivered by teams under his direction at Lion Strategy or its predecessor firm, Hambalt. Client confidentiality is absolute; cases are anonymised except where the work is already on the public record.